Integrated Dose Escalation for Advanced, Localized Gynecologic Cancer (The

Updated 05/17/2024

Status Completed

Clinical Trial Summary

The purpose of this study is to determine the maximum tolerated dose of integrated boost radiation therapy when given with concurrent chemotherapy (cisplatin).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01627288
Study type	Interventional
Source	Duke University
Contact
Status	Completed
Phase	N/A
Start date	June 4, 2012
Completion date	November 16, 2019

See also
	Status	Clinical Trial	Phase
	Completed	`NCT00193830` - High Dose Rate (HDR) Versus Low Dose Rate (LDR) Brachytherapy in Carcinoma Cervix	Phase 3
	Recruiting	`NCT03403465` - Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers	Phase 2
	Completed	`NCT01536392` - Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation	Phase 3
	Completed	`NCT00510250` - A Phase I/II Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical Cancer	Phase 1/Phase 2
	Not yet recruiting	`NCT05521997` - Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer	Phase 2
	Active, not recruiting	`NCT02328872` - Compass - Randomised Controlled Trial of Primary HPV Testing for Cervical Screening in Australia	N/A
	Recruiting	`NCT00292955` - Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma	Phase 2
	Terminated	`NCT03318107` - Ultrasound and Photoacoustic Imaging for Cervical Cancer	N/A
	Recruiting	`NCT00122746` - Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients	Phase 3
	Recruiting	`NCT05975593` - MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial
	Recruiting	`NCT04868097` - Predicting Adjuvant Post-operative Radiation Therapy in Patients With Cervical Cancer Stage IB2	N/A